Cargando…
A bespoke target selection tool to guide biomarker discovery in tubo-ovarian cancer
INTRODUCTION: Cancers presenting at advanced stages inherently have poor prognosis. High grade serous carcinoma (HGSC) is the most common and aggressive form of tubo-ovarian cancer. Clinical tests to accurately diagnose and monitor this condition are lacking. Hence, development of disease-specific t...
Autores principales: | Beirne, James P., Gilmore, Alan, McInerney, Caitríona E., Roddy, Aideen, Glenn McCluggage, W., Harley, Ian J.G., Abdullah Alvi, M., Prise, Kevin M., McArt, Darragh G., Mullan, Paul B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260242/ https://www.ncbi.nlm.nih.gov/pubmed/35832628 http://dx.doi.org/10.1016/j.csbj.2022.06.016 |
Ejemplares similares
-
Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma)
por: Owens, Alice R., et al.
Publicado: (2021) -
Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification
por: Roddy, Aideen C., et al.
Publicado: (2023) -
Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes
por: Feeney, Laura, et al.
Publicado: (2020) -
Impact of Variable RNA-Sequencing Depth on Gene Expression Signatures and Target Compound Robustness: Case Study Examining Brain Tumor (Glioma) Disease Progression
por: Stupnikov, Alexey, et al.
Publicado: (2018) -
NUQA: Estimating Cancer Spatial and Temporal Heterogeneity and Evolution through Alignment-Free Methods
por: Roddy, Aideen C, et al.
Publicado: (2019)